In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...

The growth rate of petrol consumption is set to fall below 5% in the current fiscal, the first time in five years. Meanwhile, the consumption of diesel continues to grow at 7%, adding to the losses of the oil marketing companies on account of subsidies. In India, diesel is subsidized while petrol is not, and the price difference has led to more buyers opting for vehicles driven by the cheaper fuel. According...

An international conference on agriculture beginning here on Tuesday will debate the multiple challenges faced by women in farms across developing economies, including finding gender-sensitive solutions to reduce drudgery involved in farm work with better technology innovation. From sowing to selling farm products, women’s role in agriculture has been globally recognized, A. Ayyappan, director general of Indian Council of Agricultural Research (ICAR), told reporters on Monday. The three-day conference will address...

Ten years after the killings in Gujarat, Narendra Modi has neither expressed regret nor has he been held accountable for those mass deaths. Where do we go from here? Anand Teltumbde (tanandraj@gmail.com) is a writer and civil rights activist with the Committee for the Protection of Democratic Rights, Mumbai.   Just thinking of it, a shiver runs down my spine. I had my own brush with how the Hindutva gangs carried out the...

In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licencing approval, the Indian Patent Office on Monday cleared the application of Hyderabad's Natco Pharma to sell generic drug Nexavar,...